Clinical and Pathological Studies in the Oldest Old
Clinical and Pathological Studies in the Oldest Old
批准号:
7575781
负责人:
CLAUDIA H. KAWAS
金额:
$134.86万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-15 至 2013-02-28
关键词:
Activities of Daily LivingAgeAged, 80 and overAlzheimer&aposs DiseaseAnemiaBiologicalBlood VesselsCaliforniaCentenarianClinicalClinical DataCognitionCognitiveCohort StudiesCollaborationsDNADataDementiaDevelopmentExerciseFutureGeneticGoalsHippocampus (Brain)Impaired cognitionIncidenceIndividualInterventionIntervention StudiesInvestigationLaboratory StudyLifeMeasuresNeuronsNonagenarianOther GeneticsOxygenOxygen Therapy CarePathologyPennsylvaniaPerformancePopulationProspective StudiesPublic HealthResearch PersonnelResourcesRiskRisk FactorsSamplingScientistSocietiesSpeedSurveysTestingUniversitiesWalkingage groupage relatedagedbasebrain tissuedisabilityfrailtyfunctional declinefunctional disabilityfunctional statusmedical schoolsmemberpopulation basedpreventprospectivepublic health relevanceresearch studysynucleintau-1
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Project Summary Initiated in 2003, the goal of The 90+Study is to perform prospective clinical, pathological, and genetic investigations in a population based sample of people aged 90 years and older. With a wealth of cognitive tests, laboratory studies, physical performance measures, genetic and other data in The 90+ Study, plus survey information collected on these individuals since 1981 as part of the Leisure World Cohort Study, we will estimate incidence rates and evaluate risk and protective factors for dementia (Aim 1), functional disability and frailty (Aim 2), as well as cognitive and functional decline in the oldest old (Aim 3). Our studies emphasize potentially modifiable factors (oxygen saturation, anemia, and physical performance) as risk factors for dementia and disability in this age group, and could potentially provide the basis for future intervention studies in the oldest old. Based on our preliminary studies, we hypothesize that poor arterial oxygen saturation is a risk factor for cognitive decline and dementia, while anemia and physical performance measures (such as walk speed and handgrip) are risk factors for the development of disability, frailty, and functional decline in demented and non demented individuals. Half of all demented subjects in this age range do not have significant classical AD or other pathologies to explain cognitive loss. In this application, new collaborations enhance our clinical pathological studies investigating the biological correlates of cognition in the oldest old (Aim 4). Brain tissues from our well characterized subjects will be studied by investigators at the University of California, Irvine, University of Pennsylvania, and Johns Hopkins School of Medicine as we test our hypotheses that soluble, rather than insoluble, oligomeric species of A2, tau and 1 synuclein may be responsible for cognitive loss in 90+ year olds (Aim 4b) and that non AD pathologies, relevant to neuronal integrity and circuits, may contribute to cognitive loss through other age related mechanisms (Aim 4c). Finally, we will develop our clinical data and biological samples (brain tissues and DNA) as a resource to be actively shared with scientists worldwide. Project Narrative Understanding factors that influence the cognitive and functional status of the most senior members of our society is a major goal of this proposal. In our prospective studies of dementia, disability, and frailty in the oldest old, we will investigate the relationship to dementia, disability, and frailty of arterial O2 saturation, anemia, physical performance measures, and other factors that might be amenable to intervention. Ultimately our goal is to find ways to extend life without disability in nonagenarians and centenarians. If low O2 saturation, anemia or poor physical performance is associated with increased risk of dementia or disability in exceptionally long life, it would provide the basis for experimental studies to determine if oxygen therapy, treatment of anemia, or exercise could prevent or delay the loss of cognition and activities of daily living in the oldest old. The potential public health implications are enormous for the fastest growing segment of our population. PUBLIC HEALTH RELEVANCE: Understanding factors that influence the cognitive and functional status of the most senior members of our society is a major goal of this proposal. In our prospective studies of dementia, disability, and frailty in the oldest-old, we will investigate the relationship to dementia, disability, and frailty of arterial O2 saturation, anemia, physical performance measures, and other factors that might be amenable to intervention. Ultimately our goal is to find ways to extend life without disability in nonagenarians and centenarians. If low O2 saturation, anemia or poor physical performance is associated with increased risk of dementia or disability in exceptionally long life, it would provide the basis for experimental studies to determine if oxygen therapy, treatment of anemia, or exercise could prevent or delay the loss of cognition and activities of daily living in the oldest-old. The potential public health implications are enormous for the fastest growing segment of our population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core B-Clinical Core
-
批准号:9922101
-
项目类别:
-
资助金额:$61.75万
-
财政年份:2020
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
LEUKOCYTE-DERIVED BIOMARKERS AS PREDICTORS OF RISK AND PROGRESSION IN ALZHEIMER'
-
批准号:8166929
-
项目类别:
-
资助金额:$1.48万
-
财政年份:2009
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
LEUKOCYTE-DERIVED BIOMARKERS AS PREDICTORS OF RISK AND PROGRESSION IN ALZHEIMER'
-
批准号:7951079
-
项目类别:
-
资助金额:$0.68万
-
财政年份:2008
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
CORE--CLINICAL
-
批准号:6932809
-
项目类别:
-
资助金额:$25.01万
-
财政年份:2005
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Core--Clinical
-
批准号:6578726
-
项目类别:
-
资助金额:$15.83万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:8230622
-
项目类别:
-
资助金额:$136.92万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:7463369
-
项目类别:
-
资助金额:$134.83万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:6907727
-
项目类别:
-
资助金额:$12.6万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Core--Education and information transfer
-
批准号:6578728
-
项目类别:
-
资助金额:$15.83万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:6934497
-
项目类别:
-
资助金额:$119.18万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:7496763
-
项目类别:
-
资助金额:$20.39万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:6659008
-
项目类别:
-
资助金额:$104.62万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:6782570
-
项目类别:
-
资助金额:$119.2万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:6507991
-
项目类别:
-
资助金额:$109.34万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:8039091
-
项目类别:
-
资助金额:$135.73万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:7112272
-
项目类别:
-
资助金额:$118.38万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Clinical and Pathological Studies in the Oldest Old
-
批准号:7796652
-
项目类别:
-
资助金额:$138.21万
-
财政年份:2002
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Core--Education and information transfer
-
批准号:6448161
-
项目类别:
-
资助金额:$15.83万
-
财政年份:2001
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Core--Clinical
-
批准号:6448159
-
项目类别:
-
资助金额:$15.83万
-
财政年份:2001
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
Core--Clinical
-
批准号:6299255
-
项目类别:
-
资助金额:$24.78万
-
财政年份:2000
-
负责人:CLAUDIA H. KAWAS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: